Disease Target Assessment
Disease Target Assessment helps disease area strategy and business development teams create new products that offer significant clinical innovation and commercial potential.
Discovery Scan is a commercial screening tool that compares medical need across diseases to help teams select targets for drug discovery or in-licensing.
Equinox Group's powerful forecast models help clients develop insights about the potential of their products in complex, fast-changing markets.
We excel at conducting both qualitative interviews with opinion-leading physicians and quantitative Web surveys to generate inputs for forecast models.